SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

CARRANZA PELEGRINA, Daniela et al. Posibilidades diagnósticas de la Tomografía por Emisión de Positrones (PET): Aplicaciones en la patología oncológica bucal y maxilofacial. Med. oral patol. oral cir. bucal (Ed.impr.) [online]. 2005, vol.10, n.4, pp.331-342. ISSN 1698-4447.

    1. Martí J. Tomógrafo emisor de positrones. En: Richter J, Martí J. PET Tomografía Molecular: fundamentos y aplicaciones. Madrid: Ediciones Eseuve; 1993. p. 15-38. [ Links ]

    2. Gámez Cerezano C, Cabrera Villegas A, Sopena Monforte R, García Velloso M. La tomografía por emisión de positrones (PET) en oncología (Parte I). Rev Esp Med Nucl 2002;21:41-60. [ Links ]

    3. Hemingway R, Wong W, Chevretton E, McGurk M. The use of positron emission tomography in the evaluation of orofacial malignancy disease. Br Dent J 1996;181:250-3. [ Links ]

    4. Stuckensen T, Kóvacs A, Adams S, Baum R. Staging of the neck in patients with oral cavity squamous cell carcinoma: a prospective comparison of PET, ultrasound, CT and MRI. J Cranio Maxillofac Surg 2000;28:319-24. [ Links ]

    5. Phelps M. PET: The merging of biology and imaging into molecular imaging. J Nucl Med 2000;41:661-81. [ Links ]

    6. Fowler J, Volkow N, Wang G, Ding Y, Dewey S. PET and drug research development. J Nucl Med 1999;40:1154-63. [ Links ]

    7. Hustinx R, Eck S, Alavi A. Potencial applications of PET imaging in developing. Novel cancer therapies. J Nucl Med 1999: 995-1002. [ Links ]

    8. Sutinen E, Jyrkkio S, Alanen K, Nagren K, Minn H. Uptake of [ N-methyl -(11)C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med Mol Imaging 2003;30:72-7. [ Links ]

    9. Cabrera Villegas A, García Velloso M, Gámez Cerezano C. Tomografía por emisión de positrones (PET) en oncología clínica (Parte III). Rev Esp Med Nuclear 2002;21:304-23. [ Links ]

    10. Perie S, Montravers F, Kerrou K, Angelard B, Tassart M, Talbot JN et al. Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy. Ann Otol Rhinol Laryngol 2002;111:763-71. [ Links ]

    11. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wiesser S, Heinisch M, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001;28:816-21. [ Links ]

    12. Gómez Muñoz J, López Martín J, Borrego Dorado I, Vázquez Albertino, Oliveras Moreno, García Perla A. Indicaciones de la Tomografía por emisión de positrones (PET) en cirugía maxilofacial. Rev Esp Cirug Oral y Maxilofac 2002;24:70-4. [ Links ]

    13. Braams J, Pruim J, Kole A, Nikkels P, Vaalburg W, Vermey A. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 1997;26:112-5. [ Links ]

    14. Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck 2001;23:1056-60. [ Links ]

    15. Klabbers BM, de Munck JC, Slotman BJ, Langendijk HA, de Bree R, Hoekstra OS, et al. Matching PET and CT scans of the head and neck area: development of method and validation. Med Phys 2002;29:2230-8. [ Links ]

    16. Braams J, Pruim J, Freling N, Nikkels P, Roodenburg J. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-6. [ Links ]

    17. Lowe V, Boyd J, Dunphy F, Kim H, Dunleavy T, Collins B, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18:651-8. [ Links ]

    18. Kao C, ChangLai S, Chieng P, Yen R, Yen T. Detection of recurrent or persitent nasopharyngeal carcinomas after radiotherapy 18- fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998;16:3550-5. [ Links ]

    19. Schechter NR, Gillenwater AM, Byers RM, Garden AS, Morrison WH, Nguyen LN, et al. Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int J Radiat Oncol Biol Phys 2001;51:4-9. [ Links ]

    20. Anzai Y, Carroll W, Quint D, Bradford C, Minoshima S, Wolf G, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2- deoxy-2 (F-18) fluoro-D- glucose PET and MRI imaging diagnoses. Radiol 1996;200:135-41. [ Links ]

    21. Mc Guirt W, Greven K, Williams D, Keyes J, Watson N, Capellari J, et al. PET scanning in head and neck oncology: a review. Head Neck 1998;20:208-15. [ Links ]

    22. Lapela M, Eigtved A, Jyrkiö S, Grénman R, Kurki T, Lindholm P. Experience in qualitative and quantitative FDG-PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000; 6:858-67. [ Links ]

    23. Kluetz P, Meltzer C, Villemagne V, Kinahan P, Chander S. Combined PET/CT imaging in Oncology: Impact on patient management. Clin Positron Imag 2000;3:223-30. [ Links ]

    24. Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med Mol Imaging 2002;29:367-70. [ Links ]

    25. Farber LA, Benard F, Machtay M, Smith RJ, Weber RS, Weinstein GS, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109:970-5. [ Links ]

    26. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography. Oral Oncol 1999;35:390-4. [ Links ]

    27. Wong RJ, Lin DT, Schoder H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-208. [ Links ]

    28. Regelink G, Brouwer J, de Bree R, Pruim J, van der Laan BF, Vaalburg W, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging 2002;29:1024-30. [ Links ]

    29. Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128:703-7. [ Links ]

    30. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002;236:208-17. [ Links ]